The biotherapeutic manufacturing landscape demands increasingly sophisticated approaches to cell culture optimization, where media selection can make or break product timelines and commercial success.
Microbial systems offer distinct advantages in protein expression, saving costs and time, and offering well-characterized host genetics and ease of scale-up. 2 However, challenges remain in process ...
See the technical jobs that have emerged with additive manufacturing, from DfAM specialists to machine operators and post processing experts.
Rapid developments in gene-modified cell therapies, especially CAR T-cell therapies, has increased demand for fast and reliable analytics methods for research, in-process development, and ...
Stay ahead in the booming mRNA market, projected to reach $63.28 billion by 2025, with the 3 rd mRNA Process Development & Manufacturing Summit 2025 - Europe’s premier industry-focused forum dedicated ...
DURHAM, N.C.--(BUSINESS WIRE)--KBI Biopharma, Inc. (KBI), a JSR Life Sciences company and global cGMP contract development and manufacturing organization (CDMO), announces a manufacturing contract ...
With the mRNA market projected to reach $63.28 billion by 2025, the global demand for mRNA vaccines and therapeutics is at an all-time high. Now more than ever, robust process development and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results